The Neurodegenerative and Infectious Diseases Group focuses on unraveling the complexities of brain disorders and infectious pathogens to pave the way for next-generation diagnostics and therapies. By combining molecular biology, drug discovery, and translational research, the group aims to transform scientific insights into meaningful solutions that improve patient outcomes and global health.
To be a leading global hub of innovation in neurodegenerative and infectious disease research, advancing knowledge from molecular insights to medical breakthroughs that transform healthcare and improve lives worldwide.
